nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—endothelium—sarcoma	0.0547	0.211	CbGeAlD
Azilsartan medoxomil—AGTR1—myometrium—sarcoma	0.0313	0.121	CbGeAlD
Azilsartan medoxomil—Hyperuricaemia—Thiotepa—sarcoma	0.029	0.0392	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Thiotepa—sarcoma	0.0274	0.037	CcSEcCtD
Azilsartan medoxomil—AGTR1—hematopoietic system—sarcoma	0.0269	0.104	CbGeAlD
Azilsartan medoxomil—AGTR1—connective tissue—sarcoma	0.0259	0.0999	CbGeAlD
Azilsartan medoxomil—Hyperuricaemia—Vincristine—sarcoma	0.0257	0.0347	CcSEcCtD
Azilsartan medoxomil—Hyperuricaemia—Mitoxantrone—sarcoma	0.0251	0.0338	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Vincristine—sarcoma	0.0243	0.0328	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Mitoxantrone—sarcoma	0.0237	0.032	CcSEcCtD
Azilsartan medoxomil—AGTR1—smooth muscle tissue—sarcoma	0.0237	0.0914	CbGeAlD
Azilsartan medoxomil—Hyperuricaemia—Etoposide—sarcoma	0.0209	0.0281	CcSEcCtD
Azilsartan medoxomil—AGTR1—cardiac atrium—sarcoma	0.0204	0.0788	CbGeAlD
Azilsartan medoxomil—Blood uric acid increased—Etoposide—sarcoma	0.0197	0.0266	CcSEcCtD
Azilsartan medoxomil—AGTR1—lymphoid tissue—sarcoma	0.0189	0.0731	CbGeAlD
Azilsartan medoxomil—Blood creatinine increased—Thiotepa—sarcoma	0.0183	0.0247	CcSEcCtD
Azilsartan medoxomil—AGTR1—tendon—sarcoma	0.0178	0.0687	CbGeAlD
Azilsartan medoxomil—Blood creatinine increased—Mitoxantrone—sarcoma	0.0158	0.0213	CcSEcCtD
Azilsartan medoxomil—AGTR1—testis—sarcoma	0.0147	0.0569	CbGeAlD
Azilsartan medoxomil—AGTR1—liver—sarcoma	0.0139	0.0538	CbGeAlD
Azilsartan medoxomil—Connective tissue disorder—Thiotepa—sarcoma	0.0133	0.0179	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Thiotepa—sarcoma	0.0123	0.0166	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Vincristine—sarcoma	0.0118	0.0159	CcSEcCtD
Azilsartan medoxomil—Hyperuricaemia—Epirubicin—sarcoma	0.0117	0.0158	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Epirubicin—sarcoma	0.011	0.0149	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Vincristine—sarcoma	0.0109	0.0147	CcSEcCtD
Azilsartan medoxomil—Hyperuricaemia—Doxorubicin—sarcoma	0.0108	0.0146	CcSEcCtD
Azilsartan medoxomil—AGTR1—lymph node—sarcoma	0.0107	0.0412	CbGeAlD
Azilsartan medoxomil—Blood uric acid increased—Doxorubicin—sarcoma	0.0102	0.0138	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00996	0.0134	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Thiotepa—sarcoma	0.00942	0.0127	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Thiotepa—sarcoma	0.00933	0.0126	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Etoposide—sarcoma	0.00882	0.0119	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Vincristine—sarcoma	0.00836	0.0113	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Thiotepa—sarcoma	0.0083	0.0112	CcSEcCtD
Azilsartan medoxomil—Fatigue—Thiotepa—sarcoma	0.00829	0.0112	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dactinomycin—sarcoma	0.00822	0.0111	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Etoposide—sarcoma	0.00813	0.011	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Mitoxantrone—sarcoma	0.00806	0.0109	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Epirubicin—sarcoma	0.00738	0.00995	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Vincristine—sarcoma	0.00736	0.00993	CcSEcCtD
Azilsartan medoxomil—Fatigue—Vincristine—sarcoma	0.00735	0.00991	CcSEcCtD
Azilsartan medoxomil—Fatigue—Mitoxantrone—sarcoma	0.00716	0.00965	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00715	0.00965	CcSEcCtD
Azilsartan medoxomil—Asthenia—Thiotepa—sarcoma	0.0069	0.0093	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dactinomycin—sarcoma	0.00684	0.00923	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Doxorubicin—sarcoma	0.00682	0.00921	CcSEcCtD
Azilsartan medoxomil—Pruritus—Thiotepa—sarcoma	0.0068	0.00917	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Etoposide—sarcoma	0.00671	0.00905	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Thiotepa—sarcoma	0.00658	0.00887	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dactinomycin—sarcoma	0.00653	0.00881	CcSEcCtD
Azilsartan medoxomil—Dizziness—Thiotepa—sarcoma	0.00636	0.00858	CcSEcCtD
Azilsartan medoxomil—Asthenia—Vincristine—sarcoma	0.00611	0.00825	CcSEcCtD
Azilsartan medoxomil—Rash—Thiotepa—sarcoma	0.00606	0.00818	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Thiotepa—sarcoma	0.00605	0.00817	CcSEcCtD
Azilsartan medoxomil—Rash—Dactinomycin—sarcoma	0.00601	0.00811	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Etoposide—sarcoma	0.00596	0.00804	CcSEcCtD
Azilsartan medoxomil—Asthenia—Mitoxantrone—sarcoma	0.00595	0.00803	CcSEcCtD
Azilsartan medoxomil—Fatigue—Etoposide—sarcoma	0.00595	0.00803	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Vincristine—sarcoma	0.00583	0.00787	CcSEcCtD
Azilsartan medoxomil—Nausea—Thiotepa—sarcoma	0.00571	0.0077	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Mitoxantrone—sarcoma	0.00568	0.00766	CcSEcCtD
Azilsartan medoxomil—Nausea—Dactinomycin—sarcoma	0.00567	0.00764	CcSEcCtD
Azilsartan medoxomil—Dizziness—Vincristine—sarcoma	0.00564	0.0076	CcSEcCtD
Azilsartan medoxomil—Rash—Vincristine—sarcoma	0.00537	0.00725	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Vincristine—sarcoma	0.00537	0.00724	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Epirubicin—sarcoma	0.00537	0.00724	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Epirubicin—sarcoma	0.00535	0.00722	CcSEcCtD
Azilsartan medoxomil—Rash—Mitoxantrone—sarcoma	0.00523	0.00706	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Mitoxantrone—sarcoma	0.00523	0.00705	CcSEcCtD
Azilsartan medoxomil—Nausea—Vincristine—sarcoma	0.00506	0.00683	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Doxorubicin—sarcoma	0.00496	0.0067	CcSEcCtD
Azilsartan medoxomil—Asthenia—Etoposide—sarcoma	0.00495	0.00668	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Doxorubicin—sarcoma	0.00495	0.00668	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Epirubicin—sarcoma	0.00494	0.00667	CcSEcCtD
Azilsartan medoxomil—Nausea—Mitoxantrone—sarcoma	0.00493	0.00665	CcSEcCtD
Azilsartan medoxomil—Pruritus—Etoposide—sarcoma	0.00488	0.00659	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Etoposide—sarcoma	0.00472	0.00637	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Doxorubicin—sarcoma	0.00457	0.00617	CcSEcCtD
Azilsartan medoxomil—Dizziness—Etoposide—sarcoma	0.00457	0.00616	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Epirubicin—sarcoma	0.00456	0.00615	CcSEcCtD
Azilsartan medoxomil—Rash—Etoposide—sarcoma	0.00435	0.00587	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Etoposide—sarcoma	0.00435	0.00587	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Doxorubicin—sarcoma	0.00422	0.00569	CcSEcCtD
Azilsartan medoxomil—Nausea—Etoposide—sarcoma	0.0041	0.00553	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00401	0.00541	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Epirubicin—sarcoma	0.00379	0.00512	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Epirubicin—sarcoma	0.00376	0.00507	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00371	0.005	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Doxorubicin—sarcoma	0.00351	0.00474	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Doxorubicin—sarcoma	0.00348	0.00469	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Epirubicin—sarcoma	0.00334	0.00451	CcSEcCtD
Azilsartan medoxomil—Fatigue—Epirubicin—sarcoma	0.00334	0.0045	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00309	0.00417	CcSEcCtD
Azilsartan medoxomil—Fatigue—Doxorubicin—sarcoma	0.00309	0.00417	CcSEcCtD
Azilsartan medoxomil—Asthenia—Epirubicin—sarcoma	0.00278	0.00375	CcSEcCtD
Azilsartan medoxomil—Pruritus—Epirubicin—sarcoma	0.00274	0.00369	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Epirubicin—sarcoma	0.00265	0.00357	CcSEcCtD
Azilsartan medoxomil—Asthenia—Doxorubicin—sarcoma	0.00257	0.00347	CcSEcCtD
Azilsartan medoxomil—Dizziness—Epirubicin—sarcoma	0.00256	0.00345	CcSEcCtD
Azilsartan medoxomil—Pruritus—Doxorubicin—sarcoma	0.00253	0.00342	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Doxorubicin—sarcoma	0.00245	0.00331	CcSEcCtD
Azilsartan medoxomil—Rash—Epirubicin—sarcoma	0.00244	0.00329	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Epirubicin—sarcoma	0.00244	0.00329	CcSEcCtD
Azilsartan medoxomil—Dizziness—Doxorubicin—sarcoma	0.00237	0.00319	CcSEcCtD
Azilsartan medoxomil—Nausea—Epirubicin—sarcoma	0.0023	0.0031	CcSEcCtD
Azilsartan medoxomil—Rash—Doxorubicin—sarcoma	0.00226	0.00305	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Doxorubicin—sarcoma	0.00226	0.00304	CcSEcCtD
Azilsartan medoxomil—Nausea—Doxorubicin—sarcoma	0.00213	0.00287	CcSEcCtD
